{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:54:01Z","timestamp":1780556041605,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["425331\/2016-4"],"award-info":[{"award-number":["425331\/2016-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.msard.2019.101858","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T02:28:40Z","timestamp":1573784920000},"page":"101858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8995-799X","authenticated-orcid":false,"given":"Rachel Dias","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Piccoli","family":"Conzatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Bornes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leise Daniele Sckenal","family":"Goi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Klein","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Cantarelli","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-6020","authenticated-orcid":false,"given":"Douglas Kazutoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2019.101858_bib0001","first-page":"1","article-title":"High-throughput flow cytometry cell-based assay to detect antibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor in human serum","author":"Amatoury","year":"2013","journal-title":"J. Vis. Exp"},{"key":"10.1016\/j.msard.2019.101858_bib0002","doi-asserted-by":"crossref","unstructured":"Bass, J., Wilkinson, D., Rankin, D., Phillips, B., Szewczyk, N., Smith, K., Atherton, P., 2017. An overview of technical considerations for western blotting applications to physiological research27, 69\u201381.","DOI":"10.1111\/sms.12702"},{"key":"10.1016\/j.msard.2019.101858_bib0003","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2019.101858_bib0004","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0005","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2019.101858_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-50","article-title":"Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays","volume":"7","author":"Chan","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2019.101858_bib0007","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458515591071","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications","volume":"22","author":"Cobo-Calvo","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2019.101858_bib0008","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.msard.2019.101858_bib0009","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitic: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2019.101858_bib0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.msard.2019.101858_bib0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0012","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3389\/fimmu.2018.02753","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disorders: toward a new spectrum of inflammatory demyelinating CNS disorders?","volume":"9","author":"Di Pauli","year":"2018","journal-title":"Front. Immunol"},{"key":"10.1016\/j.msard.2019.101858_bib0013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2019.101858_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder","volume":"9","author":"dos Passos","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.109.1.129","article-title":"Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes","volume":"109","author":"Engvall","year":"1972","journal-title":"J. Immunol"},{"key":"10.1016\/j.msard.2019.101858_bib0016","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458509106851","article-title":"Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients","volume":"15","author":"Fazio","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2019.101858_bib0017","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000011","article-title":"AQP4 autoantibody assay performance in clinical laboratory service","volume":"1","author":"Fryer","year":"2014","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2019.101858_bib0018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/14737159.2018.1431124","article-title":"N-methyl-D-aspartate receptor encephalitis: laboratory diagnostics and comparative clinical features in adults and children","volume":"18","author":"Gastaldi","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.msard.2019.101858_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2019.101858_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.pone.0079083","article-title":"An optimized immunohistochemistry technique improves NMO-IGG detection: study comparison with cell-based assays","volume":"8","author":"H\u00f6ftberger","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2019.101858_bib0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-009-0178-z","article-title":"The pathological spectrum of CNS inflammatory demyelinating diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.msard.2019.101858_bib0022","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2012.06.002","article-title":"Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry","volume":"320","author":"Jarius","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2019.101858_bib0023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.msard.2019.101858_bib0024","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ar.22424","article-title":"The basics of western blotting","volume":"295","author":"Jensen","year":"2012","journal-title":"Anat. Rec."},{"key":"10.1016\/j.msard.2019.101858_bib0026","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.msard.2019.101858_bib0027","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3343\/alm.2012.32.5.331","article-title":"Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder","volume":"32","author":"Kang","year":"2012","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.msard.2019.101858_bib0028","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jcla.21508","article-title":"Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and Elisa","volume":"26","author":"Kim","year":"2012","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.msard.2019.101858_bib0029","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2019.101858_bib0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0031","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2019.101858_bib0032","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2019.101858_bib0033","article-title":"Immunoassay techniques highlighting biomarkers in immunogenetic diseases","author":"Manole","year":"2018","journal-title":"IntechOpen"},{"key":"10.1016\/j.msard.2019.101858_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000404","article-title":"Improving the antibody-based evaluation of autoimmune encephalitis","volume":"4","author":"McCracken","year":"2017","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2019.101858_bib0035","doi-asserted-by":"crossref","unstructured":"Mclaughlin, K.A., Chitnis, T., \u03e6, J.N., Franz, B., Mcardel, S., Kuhle, J., Kappos, L., Rostasy, K., Gagne, D., Ness, J.M., \u03e6\u03e7, S.T., Connor, K.C.O., Viglietta, V., Wong, S.J., Tavakoli, N.P., Seze, J.De, Samia, J., Bar-or, A., Hafler, D.A., Banwell, B., Kai, W., 2009. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis183, 4067\u20134076.","DOI":"10.4049\/jimmunol.0801888"},{"key":"10.1016\/j.msard.2019.101858_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007766","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis","volume":"5","author":"Nakajima","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.msard.2019.101858_bib0037","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O'Connor","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2019.101858_bib0038","first-page":"1","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Persistent MOG-IGG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis","author":"Ogawa","year":"2017","journal-title":"Mult. Scler. J"},{"key":"10.1016\/j.msard.2019.101858_bib0061","article-title":"Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis","author":"Oliveira","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2019.101858_bib0039","doi-asserted-by":"crossref","unstructured":"Patrono, C., Peskar, B.A., 1987. Radioimmunoassay in basic and clinical pharmacology.","DOI":"10.1007\/978-3-642-71809-0"},{"key":"10.1016\/j.msard.2019.101858_bib0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.msard.2019.101858_bib0041","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamaneurol.2014.1581","article-title":"Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis","volume":"71","author":"Pittock","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0042","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0958-1669(97)80030-4","article-title":"Baculoviruses as expression vectors","volume":"8","author":"Possee","year":"1997","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.msard.2019.101858_bib0043","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Pr\u00f6bstel","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101858_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2019.101858_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0122037","article-title":"Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay","volume":"10","author":"Ramberger","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2019.101858_bib0046","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0047","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fneur.2018.00841","article-title":"Detection methods for autoantibodies in suspected autoimmune encephalitis","volume":"9","author":"Ricken","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0048","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101858_bib0049","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1620\/tjem.210.307","article-title":"Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica","volume":"210","author":"Takahashi","year":"2006","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.msard.2019.101858_bib0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2019.101858_bib0051","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2014.03.001","article-title":"Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system","volume":"270","author":"Tanaka","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2019.101858_bib0052","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2019.101858_bib0053","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2019.101858_bib0054","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2019.101858_bib0055","article-title":"Detection of anti-Aquaporin-4 antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int. MS J"},{"key":"10.1016\/j.msard.2019.101858_bib0056","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2019.101858_bib0057","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101858_bib0058","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101858_bib0059","first-page":"1","article-title":"Structure and functions of aquaporin-4-based orthogonal arrays of particles, in: international review of cell and molecular biology. institute of pathology, university of tubingen","author":"Wolburg","year":"2011","journal-title":"Tubingen, Germany"},{"key":"10.1016\/j.msard.2019.101858_bib0060","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody disease","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J. Neurol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819308478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819308478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:48:18Z","timestamp":1761900498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819308478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":61,"alternative-id":["S2211034819308478"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.101858","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.101858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101858"}}